Today: 21 May 2026
Browse Category

NYSE:UNH 28 January 2026 - 4 February 2026

UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth shares rose 1% to $289.75 Monday, outperforming peers as Humana, Elevance, and Cigna declined. Truist and JPMorgan cut price targets but kept positive ratings. Investors focused on Medicare Advantage payment rates and 2026 cost trends after last week’s sector sell-off. Final 2027 Medicare Advantage rates are expected in April.
UnitedHealth stock: the Medicare Advantage deadline that could drive UNH’s next move

UnitedHealth stock: the Medicare Advantage deadline that could drive UNH’s next move

UnitedHealth Group shares fell 1.8% to $286.93 Friday as investors weighed the government’s proposed 2027 Medicare Advantage rates. The Centers for Medicare & Medicaid Services set a Feb. 25 deadline for comments and plans to announce final rates by April 6. UnitedHealth’s stock had plunged nearly 20% earlier in the week after the initial rate proposal missed analyst expectations.
1 February 2026
Healthcare stocks hold up as defensive bid lingers; Pfizer, Merck earnings set the tone

Healthcare stocks hold up as defensive bid lingers; Pfizer, Merck earnings set the tone

The Health Care Select Sector SPDR Fund (XLV) rose 0.6% to $154.74 Friday, while the S&P 500 fell 0.43%. Healthcare and consumer staples were the only S&P sectors in positive territory as investors shifted to defensive stocks. Major managed-care shares lagged after a minimal proposed Medicare Advantage rate hike. Pfizer, Merck, and Eli Lilly report earnings next week.
Dow Jones today: Warsh Fed pick and hot inflation data hang over Monday’s open

Dow Jones today: Warsh Fed pick and hot inflation data hang over Monday’s open

The Dow fell 179.09 points, or 0.4%, to 48,892.47 Friday after Trump named Kevin Warsh as his pick for Fed chair and producer inflation came in hotter than expected. Thom Tillis said he would block Warsh’s confirmation until a Justice Department probe into Powell ends. The S&P 500 dropped 0.43%, Nasdaq lost 0.94%. The January U.S. jobs report is due next Friday.
UnitedHealth stock slips again after Barclays trims target — here’s what traders are watching next

UnitedHealth stock slips again after Barclays trims target — here’s what traders are watching next

UnitedHealth shares fell 1.8% to $286.93 in after-hours trading Friday after Barclays cut its price target. The stock has dropped about 18% since Monday, triggered by a 20% plunge Tuesday. UnitedHealth forecast 2026 revenue just over $439 billion, down 2% from last year, and signaled a medical care ratio of 88.8%. Several banks trimmed price targets this week, citing Medicare-related uncertainty.
31 January 2026
UnitedHealth stock dips again as Medicare Advantage rate worries hang over UNH shares

UnitedHealth stock dips again as Medicare Advantage rate worries hang over UNH shares

UnitedHealth Group shares fell 2.1% to $286.12 in late-morning trading Friday, extending losses after this week’s selloff. Investors focused on proposed 2027 Medicare Advantage payment changes, with the government’s comment period ending Feb. 25 and final rates due April 6. CMS projects a net average payment increase of 0.09% for 2027. UBS cut its price target for UnitedHealth to $410, citing rate uncertainty.
30 January 2026
UnitedHealth stock slips after-hours as PBM fee disclosure rule adds fresh pressure on UNH

UnitedHealth stock slips after-hours as PBM fee disclosure rule adds fresh pressure on UNH

UnitedHealth shares fell 0.6% to $292.29 in after-hours trading Thursday after the U.S. Labor Department proposed new disclosure rules for pharmacy benefit managers. The proposal would require PBMs to reveal fee and compensation details. Investors are also closely watching upcoming Medicare Advantage rate decisions. Related health insurer stocks showed mixed movement late Thursday.
Elevance Health stock rises as ELV steadies after cautious 2026 outlook and Medicare rate jitters

Elevance Health stock rises as ELV steadies after cautious 2026 outlook and Medicare rate jitters

Elevance Health shares rose 1% to $345.44 Thursday, leading gains in managed-care stocks after policy and earnings volatility. The company forecast 2026 adjusted EPS of at least $25.50, below analyst expectations, and warned of revenue declines amid Medicaid and ACA headwinds. Medicare Advantage payments are set for a minimal 0.09% increase in 2027, rattling the sector. ACA enrollment for 2026 dropped to about 23 million as subsidies ended.
UnitedHealth stock price today: UNH slips as Medicare Advantage rate shock still bites

UnitedHealth stock price today: UNH slips as Medicare Advantage rate shock still bites

UnitedHealth Group shares fell 1.2% to $290.50 Thursday after regulators proposed a 0.09% Medicare Advantage rate hike for 2027, far below expectations. The company warned of possible benefit cuts and a $1.6 billion charge tied to a cyberattack. UnitedHealth stock plunged 19% Tuesday after executives called the proposal “disappointing.” CMS will issue final rates by April 6.
29 January 2026
Dow Jones flattens near 49,000 as S&P 500 hits 7,000; Fed and Big Tech earnings loom

Dow Jones flattens near 49,000 as S&P 500 hits 7,000; Fed and Big Tech earnings loom

The Dow rose 49.62 points to 49,053.03 by midday Wednesday as the S&P 500 briefly topped 7,000 before retreating. Intel jumped 11.3%, while UnitedHealth plunged nearly 20% after the Trump administration proposed a 0.09% Medicare Advantage rate hike for 2027. The Fed is expected to hold rates steady. Seagate surged 19.3% on earnings.
UnitedHealth (UNH) stock rebounds after rout — what investors watch next on Medicare Advantage rates

UnitedHealth (UNH) stock rebounds after rout — what investors watch next on Medicare Advantage rates

UnitedHealth shares rose about 3% Wednesday after plunging nearly 20% Tuesday on a weak 2026 revenue forecast and a minimal 2027 Medicare Advantage payment update. The U.S. proposed a 0.09% hike in 2027 payments, far below market expectations. Investors await the final Medicare Advantage rate announcement in early April. Peers like Elevance Health also warned of ongoing cost pressures.
28 January 2026
Dow Jones today: Dow hovers near 49,000 as Fed decision and mega-cap earnings loom

Dow Jones today: Dow hovers near 49,000 as Fed decision and mega-cap earnings loom

The Dow Jones hovered near 49,000 Wednesday morning, dipping 3.56 points to 48,999.85 as UnitedHealth’s sharp fall continued to weigh on the index. The S&P 500 briefly topped 7,000, boosted by chip stocks after upbeat results from ASML and SK Hynix. The Federal Reserve’s policy decision is due at 2 p.m. EST. Meta, Microsoft, Tesla, and IBM report earnings after the bell.
UnitedHealth stock price steadies after 20% wipeout as Medicare Advantage rates loom

UnitedHealth stock price steadies after 20% wipeout as Medicare Advantage rates loom

UnitedHealth shares rose 1.2% to $286.15 early Wednesday after plunging nearly 20% Tuesday, following a draft Medicare Advantage rate update and a weak 2026 outlook. The draft proposed a 0.09% average payment increase for 2027, far below expectations, triggering an $80 billion selloff in managed care stocks. UnitedHealth expects 2026 revenue to fall to just under $439 billion, with Medicare Advantage membership dropping by up to 1.4 million.
28 January 2026
Dow Jones today: Dow futures inch up as Fed decision and Big Tech earnings loom

Dow Jones today: Dow futures inch up as Fed decision and Big Tech earnings loom

Dow futures rose about 30 points ahead of the Fed’s policy decision, with S&P 500 and Nasdaq 100 futures also up. Health insurers slumped after U.S. officials proposed a 0.09% Medicare Advantage payment hike, far below expectations. The Dow fell 409 points Tuesday, dragged by UnitedHealth, Humana, and CVS losses, while the S&P 500 and Nasdaq hit records on tech gains. Microsoft and Meta will report earnings Wednesday.
Humana stock price tumbles 21% after Medicare Advantage rate proposal — what to watch next

Humana stock price tumbles 21% after Medicare Advantage rate proposal — what to watch next

Humana shares fell 21.1% to $207.93 in after-hours trading Tuesday after the Centers for Medicare & Medicaid Services proposed a 0.09% average payment increase for Medicare Advantage in 2027, far below analyst expectations. The draft also included stricter rules on diagnosis data. U.S. health insurer stocks dropped sharply, erasing billions in market value. Comments on the proposal are due by Feb. 25.
28 January 2026
1 2 3 4 5 10

Stock Market Today

  • Silex Systems (ASX:SLX) Stock Edges Higher Within a Tight Trading Range on Active Volume
    May 21, 2026, 11:05 AM EDT. Silex Systems Ltd (ASX:SLX), operating in the Capital Goods sector, gained 4.27% to close at AUD 5.62 with steady volume of 523,148 shares. The company's price action showed controlled volatility, trading within a narrow band between AUD 5.61 and AUD 5.80 amid balanced buy and sell interest. Silex develops laser-based isotope separation technology for uranium enrichment, semiconductor materials, and medical isotopes. Its long-term valuation is driven by progress in nuclear and advanced semiconductor sectors, supported by key partnerships like Global Laser Enrichment LLC. The stock's trading pattern signals moderate liquidity and reflects investor focus on future commercialization milestones rather than near-term revenue.

Latest articles

Xanadu Jumps on $300 Million Capital Plan

Xanadu Jumps on $300 Million Capital Plan

21 May 2026
Xanadu shares rose as much as 8.9% Thursday after the Toronto company announced a $300 million equity facility and a quantum algorithm update. The Nasdaq-listed stock traded at $15.39, up $1.26, on volume of 3.1 million shares. The facility allows Xanadu to sell Class B shares over three years but does not require it. The announcement followed a sector rally sparked by new U.S. quantum funding.
GlobalFoundries shares jump after U.S. quantum funding news

GlobalFoundries shares jump after U.S. quantum funding news

21 May 2026
GlobalFoundries shares surged 12.7% to $79.75 after the company announced a $375 million letter of intent from the U.S. Department of Commerce to support quantum-chip manufacturing. Trading volume topped 3.4 million shares by mid-morning. The company also launched Quantum Technology Solutions and will pay its first quarterly dividend on July 14. The Nasdaq fell 0.4% in early trading.
Mister Car Wash Stock Drops Off Nasdaq After $3.1 Billion Deal

Mister Car Wash Stock Drops Off Nasdaq After $3.1 Billion Deal

21 May 2026
Mister Car Wash shares have stopped trading after Leonard Green & Partners closed its $3.1 billion take-private deal. Public shareholders will receive $7.00 per share in cash; the stock last traded at $7.10 on May 19. The company will be delisted from Nasdaq and has been removed from the S&P SmallCap 600, replaced by F&G Annuities & Life.
Go toTop